| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |